InvestorsHub Logo
Followers 29
Posts 2166
Boards Moderated 0
Alias Born 12/13/2016

Re: tradeherpete post# 115193

Saturday, 08/12/2017 2:37:32 AM

Saturday, August 12, 2017 2:37:32 AM

Post# of 456777
Pete, That would depend on what kind of offer Biogen has/is going to make. Pointed out before the 2-73 stands as both a threat and an opportunity to Biogen's future business. Having 2-73 in their lab for months now will quantify that for them. There are some big boys out there with lots of money especially if Congress gets of its duff and repatriates the corporate funds.. Some of them might want to challenge for the title as the top neuroscience pharma in the world if they could get access to ANAVEX's pipeline.

It will be interesting how Missling and Scarpelos play their cards.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent AVXL News